NDC product
THERAPLEX Eczema Therapy
NDC 82280-816 · THERAPLEX, LLC
Key facts
| Product NDC | 82280-816 |
|---|---|
| Proprietary name | THERAPLEX Eczema Therapy |
| Nonproprietary name | OATMEAL |
| Substances | OATMEAL |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | THERAPLEX, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M016 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC] and 2 more |
| Marketing start | Jan 10, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: